Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Investments in Marketable Securities (Tables)

Investments in Marketable Securities (Tables)

3 Months Ended

Mar. 31, 2014

Investments Classified by Contractual Maturity Date [Table Text Block]

At March 31, 2014 and December 31, 2013, held-to-maturity investments included the following:



			Maturing						Maturing
	March 31, 2014		within 1 year		after 1 year through 3 years		December 31, 2013		within 1 year		after 1 year through 3 years
Cash/money accounts	$	135	$	135	$	—	$	116	$	116	$	—
US Treasury securities	1,477		636		841		1,730		1,360		370
Government agency securities	623		476		147		382		382		—
Total	$	2,235	$	1,247	$	988	$	2,228	$	1,858	$	370

Held-to-maturity Securities [Table Text Block]

At March 31, 2014 and December 31, 2013, held-to-maturity investments were recorded in the following accounts:



	March 31, 2014		December 31, 2013
Other current assets	$	1,247	$	1,858
Other long-term assets	988		370
Total	$	2,235	$	2,228

- Definition

Tabular disclosure of all investments in certain debt and equity securities for which the entity has the positive intent and ability to hold until maturity.

+ References + Details